Currently meets criteria for PTSD, assessed by the CAPS-5 (any trauma type) - Chronic pain, assessed by greater than or equal to 4 on a scale of 0-10 pain severity over the past 3 months
Medically stable at the time of study enrollment (chronic illness and disability does not prevent attendance of outpatient therapy sessions)
Stable on psychotropic medication for past 60 days
Agreed to not change current medication or pain-related treatments over the course of the study unless medically necessary
Must be located in the state of New York for virtual assessments and treatment sessions
You may not be if
Lifetime diagnosis of schizophrenia, other psychotic disorder, or bipolar I disorder
Participation in concurrent evidence-based psychological treatment for PTSD or chronic pain during the past 3 months
Participants must not participate in an evidence-based psychological treatment for either PTSD or pain during the course of the study.
Moderate or severe substance use in the past 90 days
Cognitive impairment to the degree that the patient cannot provide informed consent or fill out assessment measures
Participants who in the PI's judgement pose a current homicidal or suicidal risk
Clareo Health | Integrated PTSD and Chronic Pain Treatment
